Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency

Lack of expression of the fragile X mental retardation protein (FMRP), due to silencing of the FMR1 gene, causes the Fragile X syndrome. Although FMRP was characterized previously to be an RNA binding protein, little is known about its function or the mechanisms underlying the Fragile X syndrome. Here we report that the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit, GluR1, was decreased in the cortical synapses, but not in the hippocampus or cerebellum, of FMR1 gene knockout mice. Reduced long-term potentiation (LTP) was also found in the cortex but not in the hippocampus. Another RNA binding protein, FXR; the N-methyl-D-aspartate receptor subunit, NR2; and other learning-related proteins including c-fos, synapsin, myelin proteolipid protein, and cAMP response element binding protein were not different between FMR1 gene knockout and wild-type mice. These findings suggest that the depressed cortical GluR1 expression and LTP associated with FMRP deficiency could contribute to the Fragile X phenotype.

[1]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[2]  I. Weiler,et al.  Synaptic regulation of protein synthesis and the fragile X protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Dambrosia,et al.  Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation , 2001, Annals of neurology.

[4]  L. Chen,et al.  Fragile X mice develop sensory hyperreactivity to auditory stimuli , 2001, Neuroscience.

[5]  Wei-Yang Lu,et al.  Activation of Synaptic NMDA Receptors Induces Membrane Insertion of New AMPA Receptors and LTP in Cultured Hippocampal Neurons , 2001, Neuron.

[6]  R. D'Hooge,et al.  Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice , 2000, Behavioural Brain Research.

[7]  Joe Z Tsien,et al.  Linking Hebb’s coincidence-detection to memory formation , 2000, Current Opinion in Neurobiology.

[8]  J. Sarvey,et al.  Fragile X (fmr1) mRNA expression is differentially regulated in two adult models of activity-dependent gene expression. , 2000, Brain research. Molecular brain research.

[9]  H. Nakanishi,et al.  AMPA–Kainate Subtypes of Glutamate Receptor in Rat Cerebral Microglia , 2000, The Journal of Neuroscience.

[10]  Stephen Maren,et al.  Long-term potentiation in the amygdala: a mechanism for emotional learning and memory , 1999, Trends in Neurosciences.

[11]  C. Shaw,et al.  The plasticity–pathology continuum: Defining a role for the LTP phenomenon , 1999, Journal of neuroscience research.

[12]  S. T. Warren,et al.  Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function , 1999, Neuroscience.

[13]  J. Lübke,et al.  Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. , 1999, Science.

[14]  K. Svoboda,et al.  Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. , 1999, Science.

[15]  B. Oostra,et al.  Learning and memory in the FMR1 knockout mouse. , 1999, American journal of medical genetics.

[16]  M. Moser,et al.  Is learning blocked by saturation of synaptic weights in the hippocampus? , 1999, Neuroscience and Biobehavioral Reviews.

[17]  I. Weiler,et al.  Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. , 1999, American journal of medical genetics.

[18]  T. Soderling,et al.  Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[20]  G. Dawson,et al.  Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein , 1999, Neuroscience.

[21]  H. Luhmann,et al.  Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. , 1999, Journal of neurophysiology.

[22]  Yen-Chung Chang,et al.  Characterization of Granular Particles Isolated from Postsynaptic Densities , 1998, Journal of neurochemistry.

[23]  Gary W. Donaldson Ridit scores for analysis and interpretation of ordinal pain data , 1998, European journal of pain.

[24]  Nancy R. Zahniser,et al.  Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis , 1998, Nature.

[25]  J. Medina,et al.  Learning‐specific, time‐dependent increases in hippocampal Ca2+/calmodulin‐dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity , 1998, The European journal of neuroscience.

[26]  G. Lynch Memory and the Brain: Unexpected Chemistries and a New Pharmacology , 1998, Neurobiology of Learning and Memory.

[27]  B. D. de Vries,et al.  The fragile X syndrome. , 1998, Journal of medical genetics.

[28]  C. Gunter,et al.  Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein* , 1998, The Journal of Biological Chemistry.

[29]  R. Weinberg,et al.  Enhanced expression of AMPA receptor protein at perforated axospinous synapses , 1998, Neuroreport.

[30]  J. Mandel,et al.  Analysis of Domains Affecting Intracellular Localization of the FMRP Protein , 1997, Neurobiology of Disease.

[31]  M. Krug,et al.  Design of a multiple slice interface chamber and application for resolving the temporal pattern of CREB phosphorylation in hippocampal long-term potentiation , 1997, Journal of Neuroscience Methods.

[32]  A T Hoogeveen,et al.  Animal model for fragile X syndrome. , 1997, Annals of medicine.

[33]  G Tocco,et al.  Glycine-induced long-term potentiation is associated with structural and functional modifications of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Reiss,et al.  Autistic Behaviors Among Girls with Fragile X Syndrome , 1997, Journal of autism and developmental disorders.

[35]  T. Soderling,et al.  Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. , 1997, Science.

[36]  I. Weiler,et al.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Barnes,et al.  Selective Alteration of Long-Term Potentiation-Induced Transcriptional Response in Hippocampus of Aged, Memory-Impaired Rats , 1997, The Journal of Neuroscience.

[38]  A. Reiss,et al.  Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. , 1997, American journal of medical genetics.

[39]  D. Ginty,et al.  Calcium Regulation of Gene Expression: Isn't That Spatial? , 1997, Neuron.

[40]  R. D'Hooge,et al.  Mildly impaired water maze performance in maleFmr1 knockout mice , 1997, Neuroscience.

[41]  J. Morton,et al.  Fragile X syndrome is less common than previously estimated. , 1997, Journal of medical genetics.

[42]  K. I. Blum,et al.  Impaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice , 1996, Cell.

[43]  J. Monreal,et al.  Preparation of Giant Myelin Vesicles and Proteoliposomes to Register Ionic Channels , 1996, Journal of neurochemistry.

[44]  J. Hablitz,et al.  Tetraethylammonium-induced synaptic plasticity in rat neocortex. , 1996, Cerebral cortex.

[45]  R. D'Hooge,et al.  Transgenic mouse model for the fragile X syndrome. , 1996, American journal of medical genetics.

[46]  R. D'Hooge,et al.  Long-term potentiation in the hippocampus of fragile X knockout mice. , 1996, American journal of medical genetics.

[47]  S. Warren,et al.  The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. , 1996, Human molecular genetics.

[48]  T. Webb,et al.  Prevalence of fragile X syndrome. , 1996, Journal of medical genetics.

[49]  W. Sermeus,et al.  Ridit Analysis on Ordinal Data , 1996, Western journal of nursing research.

[50]  M. Dragunow A role for immediate-early transcription factors in learning and memory , 1996, Behavior genetics.

[51]  R. Wenthold,et al.  Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  A. Reiss,et al.  Contribution of the FMR1 gene mutation to human intellectual dysfunction , 1995, Nature Genetics.

[53]  R. Nussbaum,et al.  The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.

[54]  C. Parsons,et al.  Modulation of learning processes by ionotropic glutamate receptor ligands. , 1995, Behavioural pharmacology.

[55]  J. Isaac,et al.  Evidence for silent synapses: Implications for the expression of LTP , 1995, Neuron.

[56]  E I Knudsen,et al.  Characterization of a forebrain gaze field in the archistriatum of the barn owl: microstimulation and anatomical connections , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  R. Malinow,et al.  Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice , 1995, Nature.

[58]  R. Nussbaum,et al.  FXR1, an autosomal homolog of the fragile X mental retardation gene. , 1995, The EMBO journal.

[59]  B. Oostra,et al.  Characterization of FMR1 proteins isolated from different tissues. , 1995, Human molecular genetics.

[60]  P. Hanson,et al.  Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. , 1995, The EMBO journal.

[61]  R. Porter,et al.  Anatomy and physiology of glutamate in the CNS , 1994, Neurology.

[62]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[63]  I. Weiler,et al.  Metabotropic glutamate receptors trigger postsynaptic protein synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[65]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[66]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.

[67]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[68]  Y. Ben-Ari,et al.  Novel form of long-term potentiation produced by a K+channel blocker in the hippocampus , 1991, Nature.

[69]  J. Hablitz,et al.  EPSPs in rat neocortical neurons in vitro. I. Electrophysiological evidence for two distinct EPSPs. , 1989, Journal of neurophysiology.

[70]  J. Monahan,et al.  Identification and Characterization of an N‐Methyl‐D‐Aspartate‐Specific L‐[3H]Glutamate Recognition Site in Synaptic Plasma Membranes , 1987, Journal of neurochemistry.

[71]  B. Oostra,et al.  Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. , 1998, Endocrinology.

[72]  B. Oostra,et al.  In vitro reactivation of the FMR1 gene involved in fragile X syndrome. , 1998, Human molecular genetics.

[73]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[74]  David E. Housman,et al.  Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome , 1993, Nature Genetics.

[75]  G. Collingridge,et al.  Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.